Kobayashi Pharmaceutical ... (KBYPF)

PNK: KBYPF · Real-Time Price · USD

37.43

0.00 (0.00%)

At close: Apr 30, 2025, 8:00 PM

Kobayashi Pharmaceutical Income Statement

Financials in JPY. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Revenue	165.6B	173.46B	166.26B	155.25B	150.51B	168.05B	167.48B	156.76B	152.65B
Cost of Revenue	78B	77.08B	73.93B	66.48B	65.25B	64.7B	64.36B	61.24B	62.8B
Gross Profit	87.6B	96.38B	92.33B	88.77B	85.27B	103.35B	103.12B	95.52B	89.85B
Operating Income	24.86B	25.78B	26.67B	26.07B	25.94B	26.36B	26.29B	22.93B	18.91B
Interest Income	207M	214M	85M	131M	279M	338M	289M	273M	626M
Pretax Income	13.91B	27.56B	27.95B	27.64B	26.64B	26.8B	25.3B	22.57B	20.88B
Net Income	10.07B	20.34B	20.02B	19.71B	19.2B	19.14B	18.02B	15.86B	15.33B
Selling & General & Admin	22.03B	57.61B	31.61B	31.79B	31.15B	47.76B	47.73B	44.84B	58.02B
Research & Development	9.11B	9B	8.33B	7.52B	7.34B	7.11B	7.03B	7.24B	9.91B
Other Expenses	31.61B	3.98B	986M	1.01B	1.09B	831M	834M	976M	n/a
Operating Expenses	62.74B	70.6B	65.66B	62.7B	59.32B	76.98B	76.82B	72.59B	69.6B
Interest Expense	28M	29M	18M	18M	21M	20M	35M	38M	n/a
Selling & Marketing Expenses	16.87B	27.74B	26.58B	26.59B	26.01B	42.27B	42.02B	39.34B	61.01B
Cost & Expenses	140.74B	147.68B	139.58B	129.18B	124.56B	141.69B	141.18B	133.83B	132.4B
Income Tax Expense	3.84B	7.22B	7.93B	7.92B	7.43B	7.67B	7.28B	6.71B	5.62B
Shares Outstanding (Basic)	74.34M	75.84M	77.12M	78.13M	78.16M	78.42M	79.03M	78.8M	80.22M
Shares Outstanding (Diluted)	74.34M	75.84M	77.13M	78.13M	78.16M	78.42M	79.07M	78.91M	80.22M
EPS (Basic)	135.42	268.16	259.63	252.36	245.71	244.08	228.04	201.31	191.13
EPS (Diluted)	135.42	268.16	259.59	252.36	245.71	244.08	227.95	201.03	191.14
EBITDA	21.96B	33.65B	31.86B	30.79B	29.91B	30.34B	29.59B	26.33B	22.41B
EBIT	13.94B	27.59B	27.97B	27.65B	26.66B	26.82B	25.34B	22.61B	18.91B
Depreciation & Amortization	8.02B	6.06B	5.36B	4.83B	4.11B	4.13B	3.4B	3.52B	3.5B